Max Rinkel

740 total citations
20 papers, 321 citations indexed

About

Max Rinkel is a scholar working on Clinical Psychology, Psychiatry and Mental health and Organic Chemistry. According to data from OpenAlex, Max Rinkel has authored 20 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Psychology, 3 papers in Psychiatry and Mental health and 2 papers in Organic Chemistry. Recurrent topics in Max Rinkel's work include Psychedelics and Drug Studies (6 papers), Paranormal Experiences and Beliefs (2 papers) and Neurology and Historical Studies (1 paper). Max Rinkel is often cited by papers focused on Psychedelics and Drug Studies (6 papers), Paranormal Experiences and Beliefs (2 papers) and Neurology and Historical Studies (1 paper). Max Rinkel collaborates with scholars based in United States. Max Rinkel's co-authors include Harry C. Solomon, Robert W. Hyde, Hudson Hoagland, Harold E. Himwich, Jonathan Brown, Herman C.B. Denber, Jonathan Brown, William L. Holt, Gerald L. Klerman and Alberto DiMascio and has published in prestigious journals such as New England Journal of Medicine, American Journal of Psychiatry and The Journal of Nervous and Mental Disease.

In The Last Decade

Max Rinkel

19 papers receiving 215 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Max Rinkel United States	10	167	70	51	44	43	20	321
W. Mayer-Groß United Kingdom	11	123 0.7×	39 0.6×	61 1.2×	21 0.5×	29 0.7×	30	303
R. A. Sandison United Kingdom	6	227 1.4×	63 0.9×	35 0.7×	20 0.5×	81 1.9×	18	315
D. V. Siva Sankar United States	10	94 0.6×	78 1.1×	40 0.8×	20 0.5×	27 0.6×	30	375
Hudson Hoagland United States	13	59 0.4×	93 1.3×	54 1.1×	13 0.3×	25 0.6×	43	415
Amedeo S. Marrazzi United States	9	65 0.4×	138 2.0×	64 1.3×	14 0.3×	41 1.0×	29	386
Paul H. Hoch United States	12	324 1.9×	96 1.4×	160 3.1×	21 0.5×	68 1.6×	50	641
Howard D. Fabing United States	7	85 0.5×	52 0.7×	62 1.2×	8 0.2×	40 0.9×	18	282
Stephen Szára United States	13	162 1.0×	183 2.6×	23 0.5×	12 0.3×	86 2.0×	26	398
Jack Shelton United States	9	101 0.6×	67 1.0×	154 3.0×	3 0.1×	50 1.2×	18	308
A. Dittrich Switzerland	6	369 2.2×	179 2.6×	95 1.9×	4 0.1×	148 3.4×	14	519

Countries citing papers authored by Max Rinkel

Since Specialization

Citations

This map shows the geographic impact of Max Rinkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Rinkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Rinkel more than expected).

Fields of papers citing papers by Max Rinkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Rinkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Rinkel. The network helps show where Max Rinkel may publish in the future.

Co-authorship network of co-authors of Max Rinkel

This figure shows the co-authorship network connecting the top 25 collaborators of Max Rinkel. A scholar is included among the top collaborators of Max Rinkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Rinkel. Max Rinkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rinkel, Max & Harry C. Solomon. (2007). Forehead Brain and Autonomic Nervous System.. PubMed. 117(4-6). 354–9.

Rinkel, Max, et al.. (2000). Chemical theories of psychosis.. PubMed. 18(4). 323–34. 1 indexed citations

Rinkel, Max. (1966). LSD: Problems Connected with Its Use, Misuse, and Abuse in the United States. PubMed. 8. 103–113. 2 indexed citations

Rinkel, Max. (1966). PSYCHEDELIC DRUGS. American Journal of Psychiatry. 122(12). 1415–1416. 4 indexed citations

Rinkel, Max. (1966). BIOLOGICAL TREATMENT OF MENTAL ILLNESS. The American Journal of the Medical Sciences. 252(6). 148–148. 17 indexed citations

Rinkel, Max. (1963). The Biochemical Bases of Psychoses or The Serotonin Hypothesis about Mental Diseases. American Journal of Psychiatry. 120(6). 611–612. 13 indexed citations

Rinkel, Max & Harold E. Himwich. (1960). Insulin Treatment in Psychiatry. The American Journal of the Medical Sciences. 239(3). 393–393. 10 indexed citations

Rinkel, Max, et al.. (1960). Experimental Psychiatry. V — Psilocybine, a New Psychotogenic Drug. New England Journal of Medicine. 262(6). 295–297. 16 indexed citations

DiMascio, Alberto, Gerald L. Klerman, Max Rinkel, Milton Greenblatt, & Jonathan Brown. (1958). PSYCHO-PHYSIOLOGIC EVALUATION OF PHENYLTOLOXAMINE, A NEW PHRENOTROPIC AGENT. American Journal of Psychiatry. 115(4). 301–317. 7 indexed citations

10.

Denber, Herman C.B. & Max Rinkel. (1957). PSYCHODYNAMIC AND THERAPEUTIC ASPECTS OF MESCALINE AND LYSERGIC ACID DIETHYLAMIDE ROUND TABLE. The Journal of Nervous and Mental Disease. 125(3). 423–423. 7 indexed citations

11.

Rinkel, Max. (1957). Pharmakopsychologie und Psychopathologie. American Journal of Psychiatry. 113(9). 864–864. 11 indexed citations

12.

Rinkel, Max. (1957). PHARMACODYNAMICS OF LSD AND MESCALINE. The Journal of Nervous and Mental Disease. 125(3). 424–426. 11 indexed citations

13.

Rinkel, Max. (1956). Lehrbuch der Allgemeinen Psychopathologie: Grundbegriffe und Klinik. American Journal of Psychiatry. 113(5). 478–478. 2 indexed citations

14.

Rinkel, Max, Robert W. Hyde, Harry C. Solomon, & Hudson Hoagland. (1955). CLINICAL AND PHYSIO-CHEMICAL OBSERVATIONS IN EXPERIMENTAL PsYcHosIs. 1 indexed citations

15.

Rinkel, Max, et al.. (1955). Experimental psychiatry. IV. Hallucinogens: tools in experimental psychiatry.. PubMed. 16(8). 229–32. 5 indexed citations

16.

Rinkel, Max, Robert W. Hyde, Harry C. Solomon, & Hudson Hoagland. (1955). EXPERIMENTAL PSYCHIATRY II. American Journal of Psychiatry. 111(12). 881–895. 38 indexed citations

17.

Rinkel, Max, et al.. (1954). Experimental psychiatry. III. A chemical concept of psychosis.. PubMed. 15(9). 259–64. 19 indexed citations

18.

Rinkel, Max, et al.. (1952). Mental changes experimentally produced by L. S. D. (d-Lysergic acid diethylamide tartrate). Psychiatric Quarterly. 26(1-4). 33–53. 64 indexed citations

19.

Rinkel, Max, et al.. (1952). EXPERIMENTAL SCHIZOPHRENIA-LIKE SYMPTOMS. American Journal of Psychiatry. 108(8). 572–578. 90 indexed citations

20.

Holt, William L., et al.. (1951). DECAMETHONIUM BROMIDE (C-10) IN ELECTRIC CONVULSIVE THERAPY. American Journal of Psychiatry. 107(11). 821–824. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact